Please disable your Ad Blocker to better interact with this website.

Jannah Theme License is not validated, Go to the theme options page to validate the license, You need a single license for each domain name.
News

Democrat Senator Bob Menendez Corruption Trial Set For Next Week

Will this presidential election be the most important in American history?

New Jersey Senator Bob Menendez (D-NJ) is set to go on trial for corruption charges on September 6.

The charges aimed at Menendez and his co-defendant, Salomon Melgen, dates back to the Senator’s first term where Melgen allegedly gave Menendez gifts and contributions in an effort to buy political influence.

CNN reports:

Menendez and Melgen are accused of having a “quid pro quo” relationship going as far back as 2006. Prosecutors say that in exchange for luxurious vacations and large donations to his campaign coffers, Menendez used his power to advocate for various personal and business interests of Melgen’s within the government.

More details from CNN:

Melgen allegedly flew Menendez on his own private jet or on “equally luxurious travel” to his villa at Case de Campo, a luxurious resort in the Dominican Republic featuring amenities from beaches to polo fields. At one point, Melgen allegedly purchased a three-night hotel stay for Menendez at the Park Hyatt Hotel in Paris. Prosecutors say that Menendez never acknowledged these gifts on his annual financial disclosure forms.
Melgen also donated heavily to Menendez’s campaign and legal defense funds. At one point, Melgen donated more than $770,000 to various funds supporting Menendez over a five-month period.

Melgen, a medical doctor, was facing an overbilling ruling from the government related to Medicare payments.

Concerns about corruption do not stop with Senator Menendez.

Bloomberg is reporting that Menendez got former Senate Majority Leader Harry Reid (D-NV) to seek help from the White House to address the dispute between Melgen and the federal government:

Menendez “enlisted” Reid in November 2011 to help pressure the Centers for Medicare and Medicaid Services, known as CMS, to reverse its ruling that Melgen owed $8.9 million for overbilling Medicare. Reid contacted a White House deputy chief of staff, prosecutors said.

“At that time, the Majority Leader reached out to the White House Deputy Chief of Staff, informing her that Menendez was upset about how a Florida ophthalmologist was being treated by CMS and asking that she call the agency,” according to the 30-page filing.

While the media obsesses with President Trump and Russian collusion claims, it largely ignores a serious case of possible influence buying by a U.S. Senator.

Tom Borelli

Dr. Tom Borelli is a Newsmax TV contributor and radio commentator addressing political issues from a conservative grassroots perspective. As a columnist, he has written for The Washington Times and authored articles for Newsmax Magazine, Newsmax Insider and previously was a co-host with his wife Deneen Borelli on the SiriusXM Patriot channel. Dr. Borelli appeared on numerous television programs, including the highly ranked Fox News Channel’s “The O’Reilly Factor,” “Hannity,” “The Kelly File," and "America’s News Headquarters." He has also appeared on Fox Business Network’s “Making Money with Charles Payne” and “After the Bell” as well as TheBlaze TV’s "The Glenn Beck Program" and "Dana!" Prior to working for public policy organizations, Dr. Borelli was a managing partner with the investment advisory firm of Action Fund Management, LLC and a portfolio manager for the Free Enterprise Action Fund (FEAF) where he used shareholder activism to challenge corporations that sought to profit from the growth of government. During his 25 years with the Altria Group, Inc., he built a foundation in public policy and issues management, drawing from diverse experiences ranging from basic research to corporate affairs. Dr. Borelli served as science fellow for the U.S. House of Representatives' Committee on Science, Space, and Technology during the 100th Congress. Dr. Borelli has also published scientific papers on interferon and human leukemia.

Related Articles